Table 1 Baseline information before second-line antiretroviral treatment
Variable | Category | Numerical value |
|---|---|---|
Gender (n. %) | Male | 73(60.8%) |
Female | 47(39.2%) | |
Age (years, IQR) |  | 45.2(39.8–52.3) |
Education degree (n, %) | Primary school | 61(50.8%) |
Junior middle school | 40(33.3%) | |
Illiteracy | 19(15.8%) | |
Occupation (n, %) | Farmer | 120(100%) |
Route of infection (n, %) | Paid blood donation(blood transfusion) | 115(95.8%) |
Heterosexual | 3(2.5%) | |
Blood transfusion | 1(0.8%) | |
Unknown | 1(0.8%) | |
Duration of first-line treatment (years, IQR) |  | 5.0(3.7–5.5) |
NRTIs drug resistance (n, %) | Â | 68(58.1%) |
| Â | 3TC drug resistance | 38(32.5%) |
| Â | TDF drug resistance | 57(48.7%) |
NNRTIs drug resistance (n, %) | Â | 84(71.8%) |
Lpv/r drug resistance (n, %) | Â | 0(0) |
Baseline viral load (lg10) (median, IQR) copies/ml |  | 4.58 (3.96–5.17) |
Baseline CD4 + T cells (median, IQR) cells/μl |  | 170 (100–272) |